Previous 10 | Next 10 |
2024-03-28 01:54:09 ET Summary Rapid7's stock has underperformed and been volatile, currently down -10.3% YTD. The company's fundamentals are decent, with non-GAAP profitability and operating cash flow improving. Rapid7 aims to focus on profitable growth in 2024, driven by IT ...
2024-03-26 10:27:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While macroeconomic uncertainty has put pressure on many businesses’ budgets, cybersecurity continues to be important as ever. Vast amounts of enterprises are pursuing digital transforma...
2024-03-15 08:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at TD Cowen’s 44 th Annual Health Care Conference on March 5, 2024 at 10:30 a.m. ET. The webcast will be accessible from Royalty Pharma’...
BOSTON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that management will be attending the following conferences: The Wolfe Research 'March Madness' Software Conference in New York City, NY on Tuesday...
Portfolio Receipts of $736 million in Q4 2023 and $3,049 million for FY 2023 Net cash provided by operating activities of $773 million in Q4 2023 and $2,988 million for FY 2023 Announced transactions of up to $4.0 billion in 2023 Full year 2024 guidance: Portfolio Rece...
2024-02-10 09:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips The cybersecurity market has been booming in recent years as more enterprises adopt digital transformation initiatives to enhance their productivity and efficiency. Increased digital transforma...
2024-02-08 08:53:33 ET More on Pre-market losers & stocks. Peraso Inc. (PRSO) Q3 2023 Earnings Call Transcript Tenax surges after patent win for heart failure therapy Peraso to raise ~$4M through underwritten public offering of shares and warrants Financi...
2024-02-07 23:37:03 ET Rapid7 Inc. (RPD) Q4 2023 Earnings Conference Call February 7, 2024 16:30 ET Company Participants Elizabeth Chwalk - Director of Investor Relations Corey Thomas - Chairman & Chief Executive Officer Tim Adams - Chief Financial Officer ...
2024-02-07 16:25:45 ET More on Rapid7 2024 Will Be A Good Year For Rapid7 Rapid7: Quality Business Trading Attractively In A Thriving Industry Rapid7 Q4 2023 Earnings Preview Rapid7 rises as UBS bumps rating higher on solid security services Seeking A...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 ...
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the...
2024-07-09 22:15:01 ET Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for RPD on July 9, 2024 09:06PM ET. The previous analyst recommendation was Equal-Weight. RPD was trading at $39.72 at issue of the analyst recommendation. The overall analyst consensus : BU...